StockData
CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31

Clearmind Medicine Inc.

Financials through Q3 FY2026, quarter ended Jul 31, 2026
$6.00−0.26 (-4.15%)

Close on Oct 19, 2026

Market cap
$9.49M
P/E (TTM)
–
Dividend yield
–

Clearmind Medicine Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Clearmind Medicine does not break out revenue by segment, region or product in the tagged data of its filings for this period type.